Pathological study of the onset and progression in experimental immune complex glomerulonephritis--the effect of protamine sulfate and heparin
Kure, N.; Hirabayashi, K.; Ishitobi, F.; Iidaka, K.
Nihon Jinzo Gakkai Shi 30(6): 661-670
1988
ISSN/ISBN: 0385-2385 PMID: 3172566 Document Number: 316763
Document emailed within 1 workday
Related Documents
Di Perri, T.; Auteri, A. 1970: Action of heparin and protamine sulfate administration on serum complement levels in man Bollettino della Societa Italiana di Biologia Sperimentale 46(20): 817-819Sasaki, M.; Horiguchi, S.; Chiba, Y. 2011: Influence of protamine sulfate as neutralizer of heparin on a vancomycin assay in serum Rinsho Byori. Japanese Journal of Clinical Pathology 59(7): 656-661
Poon, M.C.; Hurst, R.E.; Rives, M.S. 1982: Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density Thrombosis and Haemostasis 47(2): 162-165
Suemasu, K.; Ishikawa, S. 1970: Inhibitive effect of heparin and dextran sulfate on experimental pulmonary metastases Gan 61(2): 125-130
Sugiyama, H.; Makino, H.; Wada, J.; Ota, K.; Nagake, Y.; Morioka, S.; Yamasaki, Y.; Shikata, K.; Kashihara, N.; Ikeda, S. 1993: A clinicopathological study of patients with immune complex type and pauci immune type rapidly progressive glomerulonephritis Nihon Jinzo Gakkai Shi 35(6): 777-782
Kusunoki, N.; Kuroda, M.; Otani, I.; Akiyama, T. 1977: Onset and progression of glomerulonephritis and complements Nihon Rinsho. Japanese Journal of Clinical Medicine 35(6): 2108-2114
Phillips, S.J.; Zeff, R.H. 1983: Effect of protamine sulfate after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 85(4): 641-642
Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1991: Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin Seminars in Thrombosis and Hemostasis 17(Suppl 1): 60-64
Germuth, F.G.; Rodriguez, E.; Lorelle, C.A.; Trump, E.I.; Milano, L.; Wise, O. 1979: Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis Laboratory Investigation; a Journal of Technical Methods and Pathology 41(4): 360-365
Suzuki, Y.; Oite, T.; Shimizu, F.; Yamamoto, K.; Suzuki, S.; Arakawa, M. 1984: Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis--a possible antigen excess effect on rheumatoid factor-IgG complexes Clinical and Experimental Immunology 58(3): 663-671
Germuth, F.G.; Rodriguez, E.; Lorelle, C.A.; Trump, E.I.; Milano, L.L.; Wise, O. 1979: Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits Laboratory Investigation; a Journal of Technical Methods and Pathology 41(4): 366-371
Morita, Y.; Makino, H.; Ota, K.; Wada, J.; Shikata, K.; Kashihara, N.; Ikeda, S.; Ogura, T.; Ota, Z. 1994: Effect of heparin and low-molecular-weight heparin on proliferative glomerulonephritis Nihon Jinzo Gakkai Shi 36(7): 832-838
van Elven, E.H.; Agterberg, J.; Sadal, S.; Gleichmann, E. 1981: Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. II. Autoantibodies deposited along the basement membrane of skin and their relationship to immune-complex glomerulonephritis Journal of Immunology 126(5): 1684-1691
Moriber-Katz, S.; Loose, J.; Miller, A.S.; Schwartz, A.B. 1988: IgE and immune complex glomerulonephritis Annals of Clinical and Laboratory Science 18(1): 34-38
Doutremepuich, C.; Bonini, F.; de Seze, O.; Toulemonde, F.; Bayrou, B. 1986: Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. in vitro and in vivo study Therapie 41(6): 433-436
Kozlowski, H.; Hrabowska, M. 1970: The development of experimental amyloidosis after the use of heparin, chondroitin sulfate and hyaluronidase Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 113(4): 424-434
Klinger, M.; Szewczyk, Z. 1986: Glomerulonephritis as an immune complex disease Postepy Higieny i Medycyny Doswiadczalnej 40(6): 613-634
Halliwell, R.E.; Blakemore, W.F. 1972: A case of immune complex glomerulonephritis in a dog Veterinary Record 90(10): 275-280
Patel, A.A.; White, C.M.; Coleman, C.I. 2007: Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention Connecticut Medicine 71(2): 93-95
Szewczyk, Z.; Klinger, M. 1977: Theoretical and experimental basis for heparin treatment of glomerulonephritis Polski Tygodnik Lekarski 32(29): 1129-1131